Danone will advance the delivery of science-based, consumer-centric innovations that are tailored to regional needs and scalable globally
Danone announced a new phase of investment in Danone’s Digital Lab (D-Lab) in Singapore, reinforcing the company’s commitment to advancing digital health innovation and expanding its global research and innovation (R&I) footprint.
Danone will accelerate the D-Lab’s capabilities in digital science, data analytics, and AI-driven health solutions with a particular focus on healthy nutrition for an ageing population – a growing public health priority in the region. Danone will advance the delivery of science-based, consumer-centric innovations that are tailored to regional needs and scalable globally.
This reflects the long-standing partnership between Danone and the Singapore Economic Development Board (EDB), including a joint initiative linked to digital health in 2018 that was launched at the time of the inauguration of Danone’s OneBiome Lab Singapore, with a focus on studying the gut microbiome. With the support of EDB, the Agency of Science, Technology and Research (A*STAR) and other local institutions, Danone has built and grown a thriving ecosystem in Singapore to advance digital health services. These services, which enable early screening, continuous monitoring, and nutritional management of health conditions, are now serving as a model to be rolled out and scaled globally.
“Singapore is a global innovation hub with a vibrant ecosystem of scientific talent, world-class experts and strong institutional partnerships,” said Christian Stammkoetter, Danone’s President of Asia, Middle East and Africa. “By bringing together local insight with our global expertise in science-based innovation, we see powerful opportunities to address demographic challenges like ageing, a rising priority across the region. Through digital technologies, we aim to turn data into actionable insights that improve health outcomes locally and globally.”
“We are proud to support Danone’s continued R&D efforts to unlock wider opportunities such as better health management and preventive healthcare. The next phase of D-Lab will complement Singapore’s healthy ageing initiatives and also strengthen Singapore’s position as a global health innovation hub for companies to develop and scale their solutions globally,” said Chan Ih-Ming, Executive Vice President, Digital Economy and Hub Service Industry Group, EDB.
